Oversight Committee of the Cancer Prevention and Research Institute of Texas Meeting Minutes
The committee reviewed reports from the CEO, Chief Scientific Officer, Chief Product Development Officer, and Chief Compliance Officer regarding grant award recommendations for academic research and product development programs. Key discussions included appointment approvals for various advisory committees, the adoption of an honoraria policy, the approval of health and safety code waivers, and proposed rule amendments. Additionally, the committee reviewed internal auditor reports, grant management platform modernization updates, and authorized the disbursement of grant funds via advance payments. Financial matters, including the operating budget, bond issuance resolutions, and legislative appropriations requests for the 2028-2029 biennium, were also addressed.